CD274 and neoplasm: In addition to the non-tumor cells mentioned above, PD-L1 expression on neutrophils, fibroblasts, and B cells also has been reported to play an important role in regulating anti-tumor immunity and influencing patients’ response to anti-PD therapy (124).